Investor Alert: Kirby McInerney LLP continues to investigate shareholder claims on behalf of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) – QNT Press Release


New York, January 3, 2022 (Global News Agency) – Kirby McKinney Law Firm Announced that the person who acquired Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (“Instadose” or the “Company”) filed a class-action lawsuit (over-the-counter transaction:National Bureau of Statistics) Ordinary shares from December 8, 2020 to November 24, 2021 (inclusive) (“Class Action Period”). Investors must apply to the court for appointment as the lead plaintiff of the lawsuit before February 28, 2022.

Instadose’s predecessor was Mikrocoze, Inc. (“Mikrocoze), which aimed to sell micro-furnitures in small spaces via the Internet. The company has since shifted its business to focus on the growth and acquisition of pharmaceutical-grade agricultural products.

On December 7, 2020, Instadose (still known as Mikrocoze at the time) signed a non-binding letter of intent with Canadian cannabis producer Instadose Pharma Corp. (“Instadose Canada”) and the holders of most of its outstanding shares. A transaction to acquire 100% of Instadose Canada’s issued common stock in exchange for approximately 80% of the company’s issued and issued common stock after the transaction (“Business Combination”).

The full story on Benzinga.com



Source link

Recommended For You

About the Author: News Center